BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06890338-completion@plaintrial.com
DTSTAMP:20261027T201648Z
DTSTART;VALUE=DATE:203002
SUMMARY:A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused
  Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Dia
 gnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithe
 lial Ovarian\, Fallopian Tube or Primary Peritoneal Cancer. — estimated 
 completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06890338
URL:https://plaintrial.com/trial/NCT06890338
END:VEVENT
END:VCALENDAR